PreprintAll rights reservedbioRxiv
Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer
- 1Beckman Research Institute, City of Hope
Related
- Precision targeting using machine learning to optimize medication therapy management delivery in value-based care: A quasi-experimental study using real-world evidence
- Targeting PSMD14 increases chemotherapeutic sensitivity to gemcitabine by inhibiting the WNT/β-catenin pathway and glycolysis in pancreatic cancer.
- Preimplantation factor (PIF) links embryo-derived signaling to maternal pancreatic β-cell adaptation through an ERα-dependent pathway
- The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer
- Targeting SLC6A14-mediated nutrient competition reverses an immunosuppressive metabolic niche in pancreatic cancer.
BibTeX
@misc{ebelt2026precision,
title = {{Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer}},
author = {N. D. Ebelt and S. Loganathan and L. C. Avsharian and K. Dabrowska and N. Hansen and K. V. PATHAK and P. Pirrotte and E. R. Manuel},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.01.756059},
url = {https://www.biorxiv.org/content/10.64898/2026.10.01.756059v1},
}
RIS
TY - UNPB
TI - Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer
AU - N. D. Ebelt
AU - S. Loganathan
AU - L. C. Avsharian
AU - K. Dabrowska
AU - N. Hansen
AU - K. V. PATHAK
AU - P. Pirrotte
AU - E. R. Manuel
PY - 2026
DA - 2026/10/01
PB - bioRxiv
DO - 10.64898/2026.10.01.756059
UR - https://www.biorxiv.org/content/10.64898/2026.10.01.756059v1
ER -